JANE STREET GROUP, LLC - UNITED THERAPEUTICS CORP DEL ownership

UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307C902. A total of 4 filers reported holding UNITED THERAPEUTICS CORP DEL in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of UNITED THERAPEUTICS CORP DEL
ValueSharesWeighting
Q2 2024$152,298,755
+8.6%
478,100
-21.7%
0.04%
+20.7%
Q1 2024$140,244,060
+13187.3%
610,500
+12618.8%
0.03%
Q4 2023$1,055,472
-67.8%
4,800
-66.9%
0.00%
-100.0%
Q3 2023$3,275,115
+261.9%
14,500
+253.7%
0.00%
Q2 2023$905,075
-92.9%
4,100
-92.8%
0.00%
-100.0%
Q1 2023$12,810,512
-21.7%
57,200
-2.7%
0.01%
-37.5%
Q4 2022$16,351,692
+114.6%
58,800
+61.5%
0.01%
+166.7%
Q3 2022$7,621,000
-52.8%
36,400
-46.9%
0.00%
-57.1%
Q2 2022$16,141,00068,5000.01%
Other shareholders
UNITED THERAPEUTICS CORP DEL shareholders Q2 2022
NameSharesValueWeighting ↓
JANE STREET GROUP, LLC 68,500$16,141,0000.01%
SIMPLEX TRADING, LLC 3,500$824,0000.00%
GROUP ONE TRADING, L.P. 3,700$872,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of UNITED THERAPEUTICS CORP DEL shareholders